1. Home
  2. STIM vs QTRX Comparison

STIM vs QTRX Comparison

Compare STIM & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STIM
  • QTRX
  • Stock Information
  • Founded
  • STIM 2003
  • QTRX 2007
  • Country
  • STIM United States
  • QTRX United States
  • Employees
  • STIM N/A
  • QTRX N/A
  • Industry
  • STIM Medical/Dental Instruments
  • QTRX Biotechnology: Laboratory Analytical Instruments
  • Sector
  • STIM Health Care
  • QTRX Industrials
  • Exchange
  • STIM Nasdaq
  • QTRX Nasdaq
  • Market Cap
  • STIM 232.3M
  • QTRX 233.5M
  • IPO Year
  • STIM 2018
  • QTRX 2017
  • Fundamental
  • Price
  • STIM $3.46
  • QTRX $6.12
  • Analyst Decision
  • STIM Buy
  • QTRX Buy
  • Analyst Count
  • STIM 4
  • QTRX 5
  • Target Price
  • STIM $6.00
  • QTRX $15.60
  • AVG Volume (30 Days)
  • STIM 503.9K
  • QTRX 749.4K
  • Earning Date
  • STIM 08-11-2025
  • QTRX 08-07-2025
  • Dividend Yield
  • STIM N/A
  • QTRX N/A
  • EPS Growth
  • STIM N/A
  • QTRX N/A
  • EPS
  • STIM N/A
  • QTRX N/A
  • Revenue
  • STIM $89,448,000.00
  • QTRX $135,688,000.00
  • Revenue This Year
  • STIM $104.65
  • QTRX N/A
  • Revenue Next Year
  • STIM $10.69
  • QTRX $14.49
  • P/E Ratio
  • STIM N/A
  • QTRX N/A
  • Revenue Growth
  • STIM 22.16
  • QTRX 7.71
  • 52 Week Low
  • STIM $0.52
  • QTRX $4.05
  • 52 Week High
  • STIM $5.92
  • QTRX $16.74
  • Technical
  • Relative Strength Index (RSI)
  • STIM 32.40
  • QTRX 55.97
  • Support Level
  • STIM $3.35
  • QTRX $5.98
  • Resistance Level
  • STIM $3.90
  • QTRX $6.76
  • Average True Range (ATR)
  • STIM 0.18
  • QTRX 0.52
  • MACD
  • STIM -0.03
  • QTRX 0.09
  • Stochastic Oscillator
  • STIM 17.63
  • QTRX 56.46

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Share on Social Networks: